Dr. Ong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-669-2501Fax+1 323-669-4627
Education & Training
University of Colorado School of Medicine/National Jewish Health (Pediatric)Fellowship, Allergy and Immunology, 1999 - 2002
Adventist Health White MemorialResidency, Pediatrics, 1996 - 1999
Loma Linda University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2027
CO State Medical License 2000 - 2003
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
- A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21
Publications & Presentations
PubMed
- CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity.H Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, Agustin Calatroni, Steven R Gill
The Journal of Allergy and Clinical Immunology. 2025-02-01 - 2 citationsAtopic Dermatitis (Eczema) Guidelines 2023: Highlights.Anna De Benedetto, Mark Boguniewicz, Peck Y Ong, Derek K Chu, Lynda C Schneider
The Journal of Allergy and Clinical Immunology. in Practice. 2024-11-01 - Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials.Ogechi Obed, Albert C Chong, Malcolm Su, Peck Y Ong
Expert Opinion on Emerging Drugs. 2024-09-01
Press Mentions
Study Focuses on Adolescent Data in Upadacitinib AD TrialsApril 26th, 2023- Eczema's Cause Could Be in the Air We BreatheMarch 26th, 2023
New AD Estimate: As Many as 16.5 Million Adults Have ADOctober 30th, 2018- Join now to see all
Grant Support
- Antimicrobial Peptide Expression And Staphylococcus Aureus ColonizationNational Center For Research Resources2006–2008
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
